| Patient & Visitor Guide | Medical Professionals | Guide to Lab Services | Education & Research | Who We Are |
The adverse effects of transfusion and their frequency are shown in Table 4:
|
Risk |
Type of Risk |
Frequency |
|
Hemolytic reaction |
Acute |
1:13,000 |
|
Delayed |
1:9,000 |
|
|
Febrile, non-hemolytic |
|
1:500; 1:15 platelet pools |
|
TRALI |
|
1:100,000; 1:10,000 platelet pools |
|
Allergic |
|
1:250; 1:25 platelet pools |
|
Anaphylaxis |
|
1:23,000; 1:1,600 platelet pools |
|
Graft vs Host disease |
|
Probably <1:1 million |
|
Circulatory overload |
|
~ 1% of recipients |
|
Air embolism |
|
Very rare |
|
Exogenous material |
|
Very rare |
|
Hypothermia Citrate toxicity Hyper/hypokalemia |
|
Unlikely unless >1.5 blood volumes transfused |
|
Iron Overload |
|
Begins after 20th unit |
|
Alloimmunization |
RBCs |
8% of recipients |
|
Platelets |
50% in multiply transfused |
|
|
Viral infections |
HIV |
1:4 million |
|
HTLV-I & II |
Virtually nil |
|
|
HAV |
Very rare |
|
|
HBV |
1:31,000 to 1:82,000 |
|
|
HCV |
1: 3 million |
|
|
HGV |
Common, no known disease |
|
|
TTV |
Common, no known disease |
|
|
CMV |
Unknown; CMV neg to high risk |
|
|
Parvovirus B19 |
Disease rare |
|
|
WNV |
See recent CBS info |
|
|
Prions |
CJD, vCJD |
Theoretical |
|
Bacterial agents |
Sepsis, severe symptomatic |
1:500,000; 1:10,000 platelet pools |
|
Syphilis |
Virtually nil |
|
|
Ehrlichiosis |
Very rare |
|
|
Lyme disease |
Theoretical |
|
|
Parasites |
Malaria |
1:4 million |
|
Babesiosis |
Very rare |
|
|
Chagas’ disease |
Very rare |
The above information is mainly derived from data published by Kleinman et al (2003), Ref. 18,19.